Japanese hospital to test new cancer therapy
2011-01-20 0:00

From: Google/AFP

Medical researchers in Japan say they will start the world’s first clinical studies of a radiation therapy using accelerator-based neutron beams to kill cancer cells.

The National Cancer Centre in Tokyo and a Japanese medical equipment maker -- Cancer Intelligence Care Systems -- plan to start the studies using "boron neutron capture therapy (BNCT)" in three years, the centre said.

The BNCT is an innovative radiation treatment which kills cancer cells selectively without side-effects, but it requires a massive facility including a nuclear reactor to produce neutron beams.

By using a particle accelerator, which is cheaper, safer and smaller than a reactor, it will become feasible for a hospital to provide the therapy on actual patients, the centre told journalists Tuesday.

The centre hopes to try the special radiation therapy on patients with cancers that have been difficult to treat in conventional procedures, such as brain tumors and melanoma, it said.


Article from: google.com


The boron neutron capture therapy(BNCT) is a promising method of cancer treatment in principle, which kills cancer cells selectively by the use of cancer seeking boron compound and the neutron irradiation. Source





Boron neutron capture therapy for brain tumours
From: CancerHelp.org.uk

Boron neutron capture therapy (BNCT) is an experimental way of giving radiotherapy that has been used in trials with glioblastoma multiforme (grade 4 glioma). There are concerns that the treatment causes severe side effects, so trials continue in Europe and the USA. The trials are looking into using this treatment after surgery to try to reduce the risk of the brain tumours coming back.

BNCT is really a combination of treatment with boron and fast neutrons. Radiotherapy using neutrons can get rid of glioblastoma cells. Unfortunately, at the dose needed to do this, too much damage is caused to healthy brain tissue.

In BNCT, boron is injected into the bloodstream and collects in tumour cells. The next stage of the treatment is external radiotherapy with low energy neutrons. The boron molecules give off radiation within the brain tumour cells when the external neutron radiation hits them. This enhances the radiation dose by about 2 or 3 times. So, a lower dose of neutron radiotherapy can be given. This makes it less likely that the neutrons will cause damage.

Unfortunately, there have been reports of damage being caused by the boron in the brain. This was an unexpected complication and more research needs to be done to confirm or deny this. There are no trials for patients going on in the UK at the moment. BNCT research is going on here, but it is still at the pre-clinical (laboratory) stage. Hopefully, this will lead to an early phase clinical trial soon.

There is an early phase trial in the US for people with newly diagnosed glioblastoma multiforme. The trial is testing BNCT with a chemotherapy drug called temozolamide. Early phase trials look at side effects, doses and whether there seems to be a response for a particular cancer. It is only in later phase 3 trials that we can see if a new treatment works any better than an existing treatment. So it will be some years before we have any long term results for BNCT.


Article from: cancerhelp.org.uk





Related Articles
Radioactive Cancer Patients: Public Health Menace?
Cancer ’is purely man-made’ say scientists after finding almost no trace of disease in Egyptian mummies
Breakthrough for cancer-hit Tasmanian Devils
Socioeconomic status predicts survival of cancer patients
US War Crimes: Cancer Rate in Fallujah Worse than Hiroshima
Major Cancer Charity to Admit It Was Wrong About Suntanning
Sunscreen scam? We spend millions on protection, so why is skin cancer still on the rise?
Insurance company targets breast cancer victims; cancels policies without their knowledge
He’s in the Army now: Wife’s cancer prompts man to enlist
Sick of pink: Commodifying Cancer


Latest News from our Front Page

4 beheaded in Saudi Arabia less than a week into King Salman's rule
2015-01-30 3:13
Comment: So when will the the "Human rights" promoting liberal west elite decide invade Saudi Arabia like they did Libya? Members of Magic Movement stage a mock execution scene in protest of Saudi Arabia beheading of eight Bangladeshi workers in October 2011. Four people have been executed in Saudi Arabia less than a week after 79-year-old King Salman assumed power following the ...
Swedish Office Block Pushes Microchips on its Staff
2015-01-30 2:12
Sweden is heading over the cliff in multiple areas, all at once. They are pushing the abolition of cash, run amok state feminism, gender war, pacification of the police and perhaps even more frightening: open borders. A policy that have given the country a "gold medal" in asylum seeker acceptance. Run away
Charlie Hebdo: Where Neocons, Zionists, Masons and Communists Converge
2015-01-30 1:20
Charlie Hebdo, raising the banner of revolt, has always regurgitated precisely what the “system” required. Charlie Hebdo (CH) came out of the New Left milieu of the 1960s and is a product of the 1968 revolt against President Charles de Gaulle. It happens that the most famous of the New Left revolts came at a time when (1) the CIA was ...
The Liberation of Auschwitz
2015-01-30 0:12
This article is perhaps a day late, but it will be some time before talk of the Holocaust subsides in the mainstream press, especially now that we are to have a vast new Holocaust Memorial Centre built with £50 million of taxpayers money in central London, to replace the rather unimpressive one that already exists in Hyde Park. In the various ...
Facebook’s New ‘Chinese-style’ Political Censorship System Goes Global
2015-01-29 4:35
Last week 21WIRE reported on Facebook’s new communitarian policy whereby readers can ‘flag’ content as “fake news” if they believe it’s not real, or if they do not like it. In the wake of the Charlie Hebdo False Flag event, the social media giant is now allowing governments to determine what is ‘good free speech’, and what is not. “An article ...
More News »